The National Center for Tumor Diseases (NCT) specifically addresses the major current weaknesses in clinical cancer research in Germany. With its focus on innovative clinical trials, the NCT enables new developments from the laboratory to be rapidly tested in the clinic to the highest standards, in order to provide better diagnosis and treatment options for patients.
Special emphasis is placed on personalized oncology, the involvement of patients as partners in research, rapid and equal patient access to innovations in cancer research, and the training of future generations of clinical cancer trialists.
» NCT IIT portfolio with the web portal for the submission of study synopses